Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity

NCT00648310 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Tolterodine 4 mg
DRUG: arm 2: Tolterodine 4 mg + local oestrogens once daily for 12 weeks

Sponsor

Università degli Studi dell'Insubria